David Cyranoski

Kyoto

ASHBi Institute for the Advanced Study of Human Biology Kyoto University Former Nature correspondent

Featured in: Favicon

nytimes.com Favicon

nature.com Favicon

scientificamerican.com Favicon

geneticliteracyproject.org Favicon

realclearscience.com Favicon

eoswetenschap.eu Favicon

saludconlupa.com

Articles

Cómo se reinventó un fraude científico

Jun 26, 2023 | saludconlupa.com | David Cyranoski
Cloning Scientist Hwang Woo-suk Gets a Second Chance. Should He? - The New York Times

Jun 21, 2023 | nytimes.com | David Cyranoski
Intellectual property and assisted reproductive technology - Nature Biotechnology

Jan 17, 2023 | nature.com | David Cyranoski
Who will own the next generation of assisted reproductive technologies?

Dec 27, 2022 | bioengineeringcommunity.nature.com | David Cyranoski
AI drug discovery booms in China - Nature Biotechnology

Aug 3, 2021 | nature.com | David Cyranoski
Famed Chinese immunologist cleared of plagiarism and fraud

Jan 25, 2021 | nature.com | David Cyranoski
Alarming COVID variants show vital role of genomic surveillance

Jan 14, 2021 | nature.com | David Cyranoski
Arab nations first to approve Chinese COVID vaccine - despite lack of public data

Dec 14, 2020 | nature.com | David Cyranoski
The UK has approved a COVID vaccine - here’s what scientists now want to know

Dec 3, 2020 | nature.com | Heidi Ledford |David Cyranoski |Richard Van Noorden
Why emergency COVID-vaccine approvals pose a dilemma for scientists

Nov 23, 2020 | nature.com | David Cyranoski

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers: 1K
Tweets: 463
DMs Open: No

No Tweets found.